Schedule 13D ownership disclosure

SOLID BIOSCIENCES INC COM NEW

Common Stock, $0.001 par value per share · CUSIP: 83422E105

Event date: 2026-03-06

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BCLS SB Investco, LPReported CIK 0001728056

    Shares: 0 · Class: 0%

  • Bain Capital Life Sciences Fund II, L.P.Reported CIK 0001773187

    Shares: 267,257 · Class: 0.3%

  • BCLS II Investco, LPReported CIK 0001818893

    Shares: 8,604,852 · Class: 8.8%

  • BCIP Life Sciences Associates, LPReported CIK 0001702921

    Shares: 32,550 · Class: 0.1%

  • BCLS II Equity Opportunities, LPReported CIK 0001814474

    Shares: 904,160 · Class: 1.0%

  • Bain Capital Life Sciences Opportunities IV, L.P.Reported CIK 0002015553

    Shares: 5,302,897 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-100348
Form type
SCHEDULE 13D/A
Filer
BCLS SB Investco, LP
CIK
CIK 1728056
Filed
Mar 10, 2026
Reporting period
Mar 06, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub